OpenVSafe by OpenVAERS
Search V-safe

66N-17903-38286

2 vaccinations 14 coded responses 20 check-ins 14 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
850 / AZ
Registered
2021-06-23
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-19
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-23
    Registered in v-safe
  3. 2021-06-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: Cognitive disorder, Dizziness — Feeling: Poor · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Dizziness, reduced sense of smell, reduced cognitive function
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-06-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Cognitive disorder, Dizziness — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Dizziness, reduced cognitive function
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-06-25
    Survey response — days 1–6 daily, dose 1
    MedDRA: Balance disorder, Cognitive disorder, Dizziness — Feeling: Poor · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Reduced cognitive function, dizziness, balance issues
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-06-25
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-06-26
    Survey response — day 7, dose 1
    MedDRA: Cognitive disorder, Dizziness — Feeling: Poor · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Dizziness, reduced cognitive function,
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-07-01
  9. 2021-07-03
    Health check-in — day 14, dose 1
    Feeling: Poor
    Adult check-in
  10. 2021-07-06
  11. 2021-07-10
    Dose 2 — Pfizer-BioNTech
  12. 2021-07-10
    Survey response — day 0, dose 2
    MedDRA: Cognitive disorder, Dizziness — Feeling: Fair · Headache, Fatigue or tiredness
    Free text: Dizziness, reduced cognitive function
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-07-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  14. 2021-07-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cognitive disorder — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Reduced cognitive function
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-07-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cognitive disorder, Hyposmia — Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Free text: Reduced sense of smell, reduced cognitive function
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-07-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Disturbance in attention, Dizziness, Parosmia — Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Dizziness, reduced cognitive function, reduced sense of smell
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-07-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cognitive disorder, Hyposmia — Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Reduced cognitive function, reduced sense of smell
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  18. 2021-07-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cognitive disorder, Hyposmia — Feeling: Fair · Site: Redness · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Reduced cognitive function, reduced sense of smell
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  19. 2021-07-17
    Survey response — day 7, dose 2
    MedDRA: Cognitive disorder — Feeling: Fair · Site: Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Reduced cognitive function
    MedDRA releases: 2024-11 · check-in free text available
  20. 2021-07-24
    Survey response — day 14, dose 2
    MedDRA: Chest pain, Dyspnoea, Influenza like illness, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Flu-like symptoms: sore throat, congestion, chest pain, slight difficulty breathing.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  21. 2021-07-31
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  22. 2021-08-07
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-08-14
    Survey response — day 35, dose 2
    MedDRA: Ageusia, Anosmia, Fatigue — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Increase in exhaustion and no ability to taste or smell.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2021-08-21
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-10-09
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  26. 2022-01-08
    Survey response — 6 months, dose 2
    MedDRA: Cognitive disorder, Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Still fatigued and having reduced cognitive function.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-06-19Pfizer-BioNTech No
22021-07-10Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — days 1–6 daily, dose 1

2021-06-23

Systemic reaction (other): Dizziness, reduced sense of smell, reduced cognitive function

2021-06-24

Systemic reaction (other): Dizziness, reduced cognitive function

2021-06-25

Systemic reaction (other): Reduced cognitive function, dizziness, balance issues

Release 9 — day 7, dose 1

2021-06-26

Systemic reaction (other): Dizziness, reduced cognitive function,

Release 9 — day 0, dose 2

2021-07-10

Systemic reaction (other): Dizziness, reduced cognitive function

Release 9 — days 1–6 daily, dose 2

2021-07-12

Systemic reaction (other): Reduced cognitive function

2021-07-13

Systemic reaction (other): Reduced sense of smell, reduced cognitive function

2021-07-14

Systemic reaction (other): Dizziness, reduced cognitive function, reduced sense of smell

2021-07-15

Systemic reaction (other): Reduced cognitive function, reduced sense of smell

2021-07-16

Systemic reaction (other): Reduced cognitive function, reduced sense of smell

Release 9 — day 7, dose 2

2021-07-17

Systemic reaction (other): Reduced cognitive function

Release 9 — day 14, dose 2

2021-07-24

Symptoms: Flu-like symptoms: sore throat, congestion, chest pain, slight difficulty breathing.

Release 9 — day 35, dose 2

2021-08-14

Symptoms: Increase in exhaustion and no ability to taste or smell.

Release 10 — 6 months, dose 2

2022-01-08

Symptoms: Still fatigued and having reduced cognitive function.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia ✓ · ✓
SDAnosmia ✓ · ✓
SDChest pain ✓ · ✓
SDCognitive disorder · · ✓
SDDyspnoea ✓ · ✓
SDFatigue ✓ · ✓
SDInfluenza like illness ✓ · ✓
SDOropharyngeal pain ✓ · ✓
SDRespiratory tract congestion ✓ · ✓
SROBalance disorder ✓ ✓ ✓
SROCognitive disorder ✓ ✓ ✓
SRODisturbance in attention ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROHyposmia ✓ ✓ ✓
SROParosmia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release